Neuroscience · Pharmacology, Toxicology and Pharmaceutics · NA
| ISSN | 00283908, 18737064 |
|---|---|
| Country | United Kingdom |
| Publisher | Elsevier Ltd. |
| Subject Areas | Neuroscience · Pharmacology, Toxicology and Pharmaceutics · NA |
| Publication Type | Journals |
| Active Years | 1962-ongoing |
| Competitiveness | 4. (61-80) Competitive |
| Publication Time | 1. Quickest (2-4 weeks) |
| Website | Visit journal |
Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 4.838 | 4.853 | 5.007 |
| 2021 | 4.999 | 5.347 | 5.454 |
| 2020 | 4.654 | 4.968 | 4.861 |
| 2019 | 4.501 | 4.497 | 4.408 |
| 2018 | 4.378 | 4.410 | 4.694 |
| 2017 | 4.353 | 4.844 | 4.805 |
| 2016 | 5.189 | 5.112 | 5.247 |
| 2015 | 5.410 | 5.727 | 5.414 |
| 2014 | 5.624 | — | — |
| 2013 | 5.104 | — | — |
| 2012 | 4.378 | — | — |
| 2011 | 5.141 | — | — |
| 2010 | 5.097 | — | — |
| 2009 | 4.074 | — | — |
| 2008 | 3.641 | — | — |
| 2007 | 3.443 | — | — |
| 2006 | 4.335 | — | — |
| 2005 | 4.046 | — | — |
| 2004 | 4.009 | — | — |
| 2003 | 3.830 | — | — |
| 2002 | 3.553 | — | — |
| 2001 | 3.972 | — | — |
| 2000 | 4.106 | — | — |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 1.489 |
| 2022 | 1.307 |
| 2021 | 1.323 |
| 2020 | 1.760 |
| 2019 | 1.638 |
| 2018 | 1.780 |
| 2017 | 2.043 |
| 2016 | 2.355 |
| 2015 | 2.547 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 191.000 |
| 2022 | 184.000 |
| 2021 | 176.000 |
| 2020 | 167.000 |
https://ees.elsevier.com/neuropharm/